Home › Liposarcoma › Pennsylvania › Pittsburgh
Liposarcoma clinical trials in Pittsburgh, PA
3 studies for Liposarcoma are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
RecruitingPhase 3
- UPMC Hillman Cancer Center, Pittsburgh
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
RecruitingPhase 3
- Allegheny General Hospital, Pittsburgh
- West Penn Hospital, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- and 4 more
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
RecruitingPhase 1
- UPMC Hillman Cancer Center, Pittsburgh
Liposarcoma trials in other cities
- Houston, TX10 studies
- Boston, MA7 studies
- Queens, NY5 studies
- New York City, NY5 studies
- St. Louis, MO5 studies
- Chicago, IL5 studies
- Edison, NJ4 studies
- Atlanta, GA4 studies
- Greenburgh, NY3 studies
- New Rochelle, NY3 studies
- Columbus, OH3 studies
- Seattle, WA3 studies
Other studies in Pittsburgh
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)41 studies
- Breast Cancer39 studies
- Colorectal Cancer32 studies
- Metastatic Cancer31 studies
- Melanoma31 studies
- Ovarian Cancer30 studies
- Endometrial Cancer23 studies
- Lung Cancer23 studies
- Prostate Cancer23 studies
- Stroke22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.